These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21984748)

  • 1. Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity.
    Sacconi S; Camaño P; de Greef JC; Lemmers RJ; Salviati L; Boileau P; Lopez de Munain Arregui A; van der Maarel SM; Desnuelle C
    J Med Genet; 2012 Jan; 49(1):41-6. PubMed ID: 21984748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Facioscapulohumeral muscular dystrophy type 2].
    Sacconi S; Desnuelle C
    Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis by sequencing: correction of misdiagnosis from FSHD2 to LGMD2A by whole-exome analysis.
    Leidenroth A; Sorte HS; Gilfillan G; Ehrlich M; Lyle R; Hewitt JE
    Eur J Hum Genet; 2012 Sep; 20(9):999-1003. PubMed ID: 22378277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD.
    de Greef JC; Lemmers RJ; van Engelen BG; Sacconi S; Venance SL; Frants RR; Tawil R; van der Maarel SM
    Hum Mutat; 2009 Oct; 30(10):1449-59. PubMed ID: 19728363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.
    Jones TI; Yan C; Sapp PC; McKenna-Yasek D; Kang PB; Quinn C; Salameh JS; King OD; Jones PL
    Clin Epigenetics; 2014; 6(1):23. PubMed ID: 25400706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1.
    Larsen M; Rost S; El Hajj N; Ferbert A; Deschauer M; Walter MC; Schoser B; Tacik P; Kress W; Müller CR
    Eur J Hum Genet; 2015 Jun; 23(6):808-16. PubMed ID: 25370034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of facioscapulohumeral muscular dystrophy 2.
    de Greef JC; Lemmers RJ; Camaño P; Day JW; Sacconi S; Dunand M; van Engelen BG; Kiuru-Enari S; Padberg GW; Rosa AL; Desnuelle C; Spuler S; Tarnopolsky M; Venance SL; Frants RR; van der Maarel SM; Tawil R
    Neurology; 2010 Oct; 75(17):1548-54. PubMed ID: 20975055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis.
    Rieken A; Bossler AD; Mathews KD; Moore SA
    Neurology; 2021 Feb; 96(7):e1054-e1062. PubMed ID: 33443126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monosomy 18p is a risk factor for facioscapulohumeral dystrophy.
    Balog J; Goossens R; Lemmers RJLF; Straasheijm KR; van der Vliet PJ; Heuvel AVD; Cambieri C; Capet N; Feasson L; Manel V; Contet J; Kriek M; Donlin-Smith CM; Ruivenkamp CAL; Heard P; Tapscott SJ; Cody JD; Tawil R; Sacconi S; van der Maarel SM
    J Med Genet; 2018 Jul; 55(7):469-478. PubMed ID: 29563141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous measurement of the size and methylation of chromosome 4qA-D4Z4 repeats in facioscapulohumeral muscular dystrophy by long-read sequencing.
    Hiramuki Y; Kure Y; Saito Y; Ogawa M; Ishikawa K; Mori-Yoshimura M; Oya Y; Takahashi Y; Kim DS; Arai N; Mori C; Matsumura T; Hamano T; Nakamura K; Ikezoe K; Hayashi S; Goto Y; Noguchi S; Nishino I
    J Transl Med; 2022 Nov; 20(1):517. PubMed ID: 36348371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies.
    Nikolic A; Jones TI; Govi M; Mele F; Maranda L; Sera F; Ricci G; Ruggiero L; Vercelli L; Portaro S; Villa L; Fiorillo C; Maggi L; Santoro L; Antonini G; Filosto M; Moggio M; Angelini C; Pegoraro E; Berardinelli A; Maioli MA; D'Angelo G; Di Muzio A; Siciliano G; Tomelleri G; D'Esposito M; Della Ragione F; Brancaccio A; Piras R; Rodolico C; Mongini T; Magdinier F; Salsi V; Jones PL; Tupler R
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous nonsense variant in
    Hamanaka K; Šikrová D; Mitsuhashi S; Masuda H; Sekiguchi Y; Sugiyama A; Shibuya K; Lemmers RJLF; Goossens R; Ogawa M; Nagao K; Obuse C; Noguchi S; Hayashi YK; Kuwabara S; Balog J; Nishino I; van der Maarel SM
    Neurology; 2020 Jun; 94(23):e2441-e2447. PubMed ID: 32467133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of the 4q35 D4Z4 repeat defines disease status in facioscapulohumeral muscular dystrophy.
    Erdmann H; Scharf F; Gehling S; Benet-Pagès A; Jakubiczka S; Becker K; Seipelt M; Kleefeld F; Knop KC; Prott EC; Hiebeler M; Montagnese F; Gläser D; Vorgerd M; Hagenacker T; Walter MC; Reilich P; Neuhann T; Zenker M; Holinski-Feder E; Schoser B; Abicht A
    Brain; 2023 Apr; 146(4):1388-1402. PubMed ID: 36100962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2.
    Lemmers RJ; Goeman JJ; van der Vliet PJ; van Nieuwenhuizen MP; Balog J; Vos-Versteeg M; Camano P; Ramos Arroyo MA; Jerico I; Rogers MT; Miller DG; Upadhyaya M; Verschuuren JJ; Lopez de Munain Arregui A; van Engelen BG; Padberg GW; Sacconi S; Tawil R; Tapscott SJ; Bakker B; van der Maarel SM
    Hum Mol Genet; 2015 Feb; 24(3):659-69. PubMed ID: 25256356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
    Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
    Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD.
    de Greef JC; Wohlgemuth M; Chan OA; Hansson KB; Smeets D; Frants RR; Weemaes CM; Padberg GW; van der Maarel SM
    Neurology; 2007 Sep; 69(10):1018-26. PubMed ID: 17785671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic features of somatic mosaicism in facioscapulohumeral dystrophy.
    Qiu L; Ye Z; Lin L; Wang L; Lin X; He J; Lin F; Xu G; Cai N; Jin M; Chen H; Lin M; Wang N; Wang Z
    J Med Genet; 2020 Nov; 57(11):777-785. PubMed ID: 32170003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and molecular diagnosis of facioscapulohumeral dystrophy type 1 (FSHD1) in 2012].
    Salort-Campana E; Nguyen K; Lévy N; Pouget J; Attarian S
    Rev Neurol (Paris); 2013; 169(8-9):573-82. PubMed ID: 24011979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Application of Optical Genome Mapping for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy.
    Shim Y; Seo J; Lee ST; Choi JR; Choi YC; Shin S; Park HJ
    Ann Lab Med; 2024 Sep; 44(5):437-445. PubMed ID: 38724225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection.
    Lemmers RJ; Osborn M; Haaf T; Rogers M; Frants RR; Padberg GW; Cooper DN; van der Maarel SM; Upadhyaya M
    Neurology; 2003 Jul; 61(2):178-83. PubMed ID: 12874395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.